Regulation of type I interferon responses, Nat. Rev. Immunol, vol.14, pp.36-49, 2014. ,
Seustained IFN-I expression during established persistent viral infection: A "bad seed" for protective immunity, Viruses, vol.10, p.12, 2017. ,
Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview, J. Exp. Med, vol.213, pp.2527-2538, 2016. ,
Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, vol.165, pp.551-565, 2016. ,
Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J. Exp. Med, vol.214, pp.1547-1555, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01534181
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand ,
, J. Exp. Med, vol.185, pp.1101-1111, 1997.
Crosspresentation: Plasmacytoid dendritic cells are in the business, Immunity, vol.27, pp.419-421, 2007. ,
The nature of the principal type I interferon-producing cells in human blood, Science, vol.284, pp.1835-1837, 1999. ,
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, Eur. J. Immunol, vol.31, pp.3388-3393, 2001. ,
Natural type I interferon-producing cells as a link between innate and adaptive immunity, Hum. Immunol, vol.63, pp.1126-1132, 2002. ,
Dengue virus activates membrane TRAIL relocalization and IFN-? production by human plasmacytoid dendritic cells in vitro and in vivo, PLOS Negl. Trop. Dis, vol.7, p.2257, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00844933
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha, Proc. Natl. Acad. Sci. U.S.A, vol.104, pp.17453-17458, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00177945
A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000. ,
The multifaceted biology of plasmacytoid dendritic cells, Nat. Rev. Immunol, vol.15, pp.471-485, 2015. ,
The innate immune system in SLE: Type I interferons and dendritic cells, Lupus, vol.17, pp.394-399, 2008. ,
Up-regulation of TLR7-mediated IFN-? production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus, Front. Immunol, vol.9, p.1957, 2018. ,
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus, Expert Opin. Ther. Targets, vol.13, pp.1147-1153, 2009. ,
CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus, J. Immunol, vol.182, pp.4448-4458, 2009. ,
Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement, Nat. Commun, vol.8, p.14253, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02075366
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science, vol.330, pp.1066-1071, 2010. ,
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-hodgkin's lymphoma, J. Clin. Oncol, vol.27, pp.4767-4773, 2009. ,
Pharmacological modulation of chemokine receptor function, Br. J. Pharmacol, vol.165, pp.1617-1643, 2012. ,
Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor, J. Biol. Chem, vol.282, pp.27354-27365, 2007. ,
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: Transfer of binding site to the CXCR3 receptor, J. Biol. Chem, vol.279, pp.3033-3041, 2004. ,
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor, Nat. Med, vol.4, pp.72-77, 1998. ,
Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo, J. Med. Chem, vol.51, pp.7915-7920, 2008. ,
An efficient method for gene silencing in human primary plasmacytoid dendritic cells: Silencing of the TLR7/IRF-7 pathway as a proof of concept, Sci. Rep, vol.6, p.29891, 2016. ,
Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proc. Natl. Acad. Sci. U.S.A, vol.103, pp.7000-7005, 2006. ,
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells, Blood, vol.105, pp.2458-2464, 2005. ,
Systemic lupus erythematosus, Nat. Rev. Dis. Primers, vol.2, p.16039, 2016. ,
Exosome-delivered microRNAs promote IFN-alpha secretion by human plasmacytoid DCs via TLR7, JCI Insight, vol.3, p.98204, 2018. ,
Enhanced IFN-alpha production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus, Arthritis Res. Ther, vol.19, p.234, 2017. ,
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus, J. Exp. Med, vol.211, pp.1969-1976, 2014. ,
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, Nature, vol.465, pp.937-941, 2010. ,
Animal models of interferon signature positive lupus, Front. Immunol, vol.6, p.291, 2015. ,
Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis, Arthritis Rheum, vol.58, pp.1107-1115, 2008. ,
Development of pristane induced mice model for lupus with atherosclerosis and analysis of TLR expression, Clin. Exp. Rheumatol, vol.34, pp.600-608, 2016. ,
Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity, PLOS Pathog, vol.9, p.1003678, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01113535
Prognostic parameters for flare in systemic lupus erythematosus, Rheumatology, vol.39, pp.1316-1319, 2000. ,
Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus, J. Exp. Med, vol.213, pp.697-713, 2016. ,
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA, Science, vol.303, pp.1529-1531, 2004. ,
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers, Nature, vol.424, pp.324-328, 2003. ,
Type I interferon in systemic lupus erythematosus and other autoimmune diseases, Immunity, vol.25, pp.383-392, 2006. ,
, Type I interferon in human autoimmunity. Front. Immunol, vol.5, p.306, 2014.
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs, J. Clin. Invest, vol.127, pp.269-279, 2017. ,
The interferon paradox: Can inhibiting an antiviral mechanism advance an HIV cure?, J. Clin. Invest, vol.127, pp.103-105, 2017. ,
Targeting type I interferon-mediated activation restores immune function in chronic HIV infection, J. Clin. Invest, vol.127, pp.260-268, 2017. ,
The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus, Int. Immunopharmacol, vol.40, pp.542-549, 2016. ,
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med, vol.197, pp.711-723, 2003. ,
The central role of dendritic cells and interferon-alpha in SLE, Curr. Opin. Rheumatol, vol.15, pp.548-556, 2003. ,
The 2018 pipeline of targeted therapies under clinical development for systemic lupus erythematosus: A systematic review of trials, Autoimmun. Rev, vol.17, pp.781-790, 2018. ,
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model, J. Exp. Med, vol.211, pp.1977-1991, 2014. ,
Cutting edge: Inhibiting TBK1 by compound II ameliorates autoimmune disease in mice, J. Immunol, vol.195, pp.4573-4577, 2015. ,
Toll-like receptor 7-stimulated tumor necrosis factor ? causes bone marrow damage in systemic lupus erythematosus, Arthritis Rheum, vol.66, pp.140-151, 2014. ,
A novel type I IFN-producing cell subset in murine lupus, J. Immunol, vol.180, pp.5101-5108, 2008. ,
, Small molecule inhibitors of CXCR4. Theranostics, vol.3, pp.47-75, 2013.
Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists, Sci. Rep, vol.6, p.30155, 2016. ,
Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype, Cell. Immunol, vol.279, pp.78-86, 2012. ,
AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies, Cell, vol.166, pp.582-595, 2016. ,
ZINC 15-Ligand discovery for everyone, J. Chem. Inf. Model, vol.55, pp.2324-2337, 2015. ,
Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics, Bioorg. Med. Chem. Lett, vol.23, pp.5721-5726, 2013. ,
Scalable molecular dynamics with NAMD, J. Comput. Chem, vol.26, pp.1781-1802, 2005. ,
CHARMM36m: An improved force field for folded and intrinsically disordered proteins, Nat. Methods, vol.14, pp.71-73, 2017. ,
SwissParam: A fast force field generation tool for small organic molecules, J. Comput. Chem, vol.32, pp.2359-2368, 2011. ,
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, J. Phys. Chem, vol.105, pp.9954-9960, 2001. ,
Improving defences at the portal of HIV entry: Mucosal and innate immunity, PLOS Med, vol.5, p.81, 2008. ,
Langevin stabilization of molecular dynamics, J. Chem. Phys, vol.114, pp.2090-2098, 2001. ,
Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses, PLOS Biol, vol.15, p.2004086, 2017. ,
Systematic discovery of regulatory motifs in human promoters and 3? UTRs by comparison of several mammals, Nature, vol.434, pp.338-345, 2005. ,
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.15545-15550, 2005. ,
,
,
, , p.9019
, Sci Adv REFERENCES
, This article cites 70 articles, 20 of which you can access for free